🔗 Share this article

An underground market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Followers are urged to message these accounts privately for source information, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where communities with numerous of members share comparison images, administration instructions and assertions of rapid UK delivery. Vendors promote the drug there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Professionals Voice Concerns

However, doctors and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to users administering substances of unknown origin.

Some experts said the demand for retatrutide could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or distributed for human use under the British medical regulations.

Several content creators try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, advertising, and customer laws, risking penalties, prosecution or prison.

Platform Response and Material Elimination

Based on the social media company, the platform has removed problematic material and prohibited associated hashtags and search suggestions. The organization stated it was dedicated to keeping the platform secure and investing in enhancing compliance measures.

Online Marketplace Activities

Investigations also discovered groups with up to nine thousand participants selling retatrutide using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, filled with images of weight loss, positive testimonials and detailed guides for mixing or administering at residence.

After minutes of entering one community, a seller posted WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Information and Pricing

Within these communities, posts show black plastic parcels with Royal Mail stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for the messaging service stated it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering materials they can’t verify. Even if the science behind retatrutide is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly experimental substance not yet approved … may expose patients to possibly significant medical dangers”.